Outcomes of Adult Patients in the Intensive Care Unit with Pseudomonas aeruginosa Pneumonia Who Received an Active Anti ‐Pseudomonal β‐Lactam: Does “S” Equal Success in the Presence of Resistance to other Anti‐Pseudomonal β‐Lactams?

ConclusionFurther study is needed, but this exploratory analysis suggests that the full APBL susceptibility profile should be considered when selecting therapy for patients withP. aeruginosa HABP/VABP.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - June 8, 2021 Category: Drugs & Pharmacology Authors: Thomas P. Lodise, Laura A. Puzniak, Lie H. Chen, Yun Tian, Rong Wei, Theresa M. Im, Sara Y. Tartof Tags: ORIGINAL RESEARCH ARTICLE Source Type: research